Return On Assets in % of aTYR PHARMA INC from Q3 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
aTYR PHARMA INC quarterly/annual Return On Assets history and change rate from Q3 2015 to Q3 2025.
  • aTYR PHARMA INC Return On Assets for the quarter ending 30 Sep 2025 was -74.7 %, a 26.3% decline year-over-year.
  • aTYR PHARMA INC annual Return On Assets for 2024 was -62.8 %, a 60.6% decline from 2023.
  • aTYR PHARMA INC annual Return On Assets for 2023 was -39.1 %, a 15.3% increase from 2022.
  • aTYR PHARMA INC annual Return On Assets for 2022 was -46.2 %, a 17.5% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

aTYR PHARMA INC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -74.7 -15.5 -26.3% 01 Jul 2025 30 Sep 2025
Q2 2025 -68.8 -19 -38.2% 01 Apr 2025 30 Jun 2025
Q1 2025 -64.8 -20.9 -47.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -62.8 -23.7 -60.6% 01 Oct 2024 31 Dec 2024
Q3 2024 -59.2 -24 -68.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -49.8 -10.8 -27.6% 01 Apr 2024 30 Jun 2024
Q1 2024 -43.9 -1.36 -3.2% 01 Jan 2024 31 Mar 2024
Q4 2023 -39.1 +7.07 +15.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -35.2 +9.79 +21.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -39.1 -1.99 -5.37% 01 Apr 2023 30 Jun 2023
Q1 2023 -42.5 -3.07 -7.78% 01 Jan 2023 31 Mar 2023
Q4 2022 -46.2 -6.88 -17.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -45 +0.21 +0.47% 01 Jul 2022 30 Sep 2022
Q2 2022 -37.1 +26 +41.2% 01 Apr 2022 30 Jun 2022
Q1 2022 -39.4 +15.5 +28.2% 01 Jan 2022 31 Mar 2022
Q4 2021 -39.3 -3.73 -10.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -45.2 -6.79 -17.7% 01 Jul 2021 30 Sep 2021
Q2 2021 -63 -27.2 -75.8% 01 Apr 2021 30 Jun 2021
Q1 2021 -54.9 -20.6 -60% 01 Jan 2021 31 Mar 2021
Q4 2020 -35.6 +17.3 +32.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -38.4 +10.7 +21.8% 01 Jul 2020 30 Sep 2020
Q2 2020 -35.9 +12.3 +25.5% 01 Apr 2020 30 Jun 2020
Q1 2020 -34.3 +17.7 +34% 01 Jan 2020 31 Mar 2020
Q4 2019 -52.9 +0.38 +0.71% 01 Oct 2019 31 Dec 2019
Q3 2019 -49.1 +4.53 +8.45% 01 Jul 2019 30 Sep 2019
Q2 2019 -48.2 +4.78 +9.03% 01 Apr 2019 30 Jun 2019
Q1 2019 -52 +4.19 +7.46% 01 Jan 2019 31 Mar 2019
Q4 2018 -53.2 +8.75 +14.1% 01 Oct 2018 31 Dec 2018
Q3 2018 -53.6 +11.6 +17.8% 01 Jul 2018 30 Sep 2018
Q2 2018 -52.9 +17.8 +25.2% 01 Apr 2018 30 Jun 2018
Q1 2018 -56.2 +10.2 +15.3% 01 Jan 2018 31 Mar 2018
Q4 2017 -62 -1.42 -2.34% 01 Oct 2017 31 Dec 2017
Q3 2017 -65.3 -7.94 -13.9% 01 Jul 2017 30 Sep 2017
Q2 2017 -70.7 -22 -45.1% 01 Apr 2017 30 Jun 2017
Q1 2017 -66.3 -25.6 -62.6% 01 Jan 2017 31 Mar 2017
Q4 2016 -60.6 -20.9 -52.8% 01 Oct 2016 31 Dec 2016
Q3 2016 -57.3 -17.3 -43.2% 01 Jul 2016 30 Sep 2016
Q2 2016 -48.7 01 Apr 2016 30 Jun 2016
Q1 2016 -40.8 01 Jan 2016 31 Mar 2016
Q4 2015 -39.6 01 Oct 2015 31 Dec 2015
Q3 2015 -40 01 Jul 2015 30 Sep 2015

aTYR PHARMA INC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -62.8 -23.7 -60.6% 01 Jan 2024 31 Dec 2024
2023 -39.1 +7.07 +15.3% 01 Jan 2023 31 Dec 2023
2022 -46.2 -6.88 -17.5% 01 Jan 2022 31 Dec 2022
2021 -39.3 -3.73 -10.5% 01 Jan 2021 31 Dec 2021
2020 -35.6 +0.75 +2.06% 01 Jan 2020 31 Dec 2020
2019 -36.3 +16.9 +31.8% 01 Jan 2019 31 Dec 2019
2018 -53.2 +8.75 +14.1% 01 Jan 2018 31 Dec 2018
2017 -62 -1.42 -2.34% 01 Jan 2017 31 Dec 2017
2016 -60.6 -20.9 -52.8% 01 Jan 2016 31 Dec 2016
2015 -39.6 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.